Over a decade ago, it was first discovered that the SUMOylation E2 UBC9 was highly expressed in the kidney.37 Subsequently, SUMO4 was implicated in the pathology of DN.31 Further studies, however, were inconsistent in associating SUMO4 with type 1 diabetes (T1D). Here, SUMO4 is linked to liver dysplastic nodule.